VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer,… Read More
Strategic Funding Led by Nimbus Synergies, Backed by Merck GHI, to Accelerate AI-Powered Collaborations VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies… Read More
Submission supported by MATINEE data showing significant and clinically meaningful reduction in annualized rate of moderate/severe exacerbations compared with placebo MISSISSAUGA, ON – GSK has submitted a Supplementary New Drug Submission… Read More
A new study led by researchers at the UBC faculty of medicine has revealed that ultrasound screening significantly improves breast cancer detection in women with dense breasts—identifying twice as many… Read More
Only one-third (34%) of respondents believe that a chronic health condition such as diabetes, asthma or heart disease can increase one’s risk of getting shingles Among those with a chronic… Read More
